fullscreen

eFinder

eFinder

Home › AI in Healthcare › Article

What to know about OpenAI's new model for life sciences research GPT-Rosalind

EuroNews · 🇫🇷 public France · · 489 words · By Marta Iraola Iribarren
AI in Healthcare Scientific Innovation Corporate Partnerships
headphones Listen to the eFinder podcast briefing
Generate a natural audio summary of this story
Daily briefing

What to know about AI in Healthcare

OpenAI has introduced GPT-Rosalind, a new AI model series designed to assist in biological research, drug discovery, and translational medicine. The company is partnering with various pharmaceutical and biotechnology firms, including Moderna and Novo Nordisk, to integrate these tools into scientific workflows.

Propaganda risk 20%
Claims checked 9
Techniques found 2
Topics 3

Coverage spectrum

Coverage gap: Low Left coverage
Left0%
Center100%
Right0%

4 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

The GPT-Rosalind model is designed to accelerate biological research and drug discovery.

Why it matters

OpenAI has launched a new artificial intelligence model designed to support research across biology, drug discovery, and translational medicine.

Common ground

The new tool, called GPT-Rosalind, is named after Rosalind Franklin, a British scientist best known for her role in the discovery of the structure of DNA.

Perspective signals

The tension in the story is sharpened by Loaded Language, Glittering Generalities: language that can make the dispute feel more urgent, personal, or adversarial than the underlying facts alone.

OpenAI has introduced GPT-Rosalind, a new AI model series designed to assist in biological research, drug discovery, and translational medicine. The company is partnering with various pharmaceutical and biotechnology firms, including Moderna and Novo Nordisk, to integrate these tools into scientific workflows.

open_in_new Read the original article: https://euronews.com/health/2026/04/17/what-to-know-about-openais-new-model-for-…

analyticsAnalysis

20%
Propaganda Score
confidence: 95%
Minor concerns. Some persuasive language detected, but largely factual.

psychologyPropaganda Techniques Detected

eFinder identified 2 propaganda techniques in this article. These signals explain how wording, emphasis, or missing context can shape a reader's interpretation.

warning
Loaded Language 70% confidence
Using words with strong emotional connotations to influence an audience.
Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.
Why it matters: Recognizing loaded language helps readers compare the article's framing with the underlying facts and with coverage from other sources.
warning
Glittering Generalities 60% confidence
Using vague, emotionally appealing phrases ('freedom', 'justice') without specifics.
Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.
Why it matters: Recognizing glittering generalities helps readers compare the article's framing with the underlying facts and with coverage from other sources.

fact_checkClaims Checked

eFinder analyzed this article and checked 9 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

check_circle Corroborated 7
verified Verified By Reference 2
check_circle
Claim 1: “OpenAI said the model delivers the best performance on tasks that require reasoning over molecules, proteins, genes, pathways, and disease-relevant biology.”
CORROBORATED
Multiple web sources, including Towards AI and OpenAI's own announcement, state the model's performance capabilities regarding molecules, proteins, genes, and pathways.
travel_explore
web search NEUTRAL — OpenAI presents GPT-Rosalind, an AI model specializing in biology, drug discovery, and translational medicine. Designed for complex scientific workflows: evidence synthesis, hypothesis generation, dat…
https://nucleovisual.com/en/OpenAI-launches-GPT-Rosalind--th…
travel_explore
web search NEUTRAL — OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.
https://openai.com/gu-IN/index/introducing-gpt-rosalind/
travel_explore
web search NEUTRAL — OpenAI has introduced GPT-Rosalind, a reasoning model built for life sciences research that assists with tasks like evidence synthesis, hypothesis generation, experiment design, and data analysis.
https://the-decoder.com/openai-launches-gpt-rosalind-a-reaso…
check_circle
Claim 2: “The GPT‑Rosalind life sciences model series is built for modern scientific work across published evidence, data, tools, and experiments, the company announced on Friday.”
CORROBORATED
Euronews and other web sources confirm the announcement that the model series is built for scientific work across evidence, data, tools, and experiments.
travel_explore
web search NEUTRAL — The GPT-Rosalind model is designed to accelerate biological research and drug discovery.The GPT‑Rosalind life sciences model series is built for modern scientific work across published evidence, data,…
https://www.euronews.com/health/2026/04/17/what-to-know-abou…
travel_explore
web search NEUTRAL — OpenAI launches GPT-Rosalind, an AI model for life sciences named after DNA pioneer, designed to accelerate drug discovery by analyzing biochemical data to aid in evidence synthesis, hypothesis genera…
https://www.aibase.com/news/27201
travel_explore
web search NEUTRAL — On Thursday, OpenAI announced it had developed a large language model specifically trained on common biology workflows. Called GPT-Rosalind after Rosalind Franklin, the model appears to differ from mo…
https://arstechnica.com/science/2026/04/openai-starts-offeri…
verified
Claim 3: “OpenAI’s CEO Sam Altman.”
VERIFIED BY REFERENCE
Confirmed by Wikipedia and multiple independent news cross-references (Axios, CNBC, Al Jazeera).
menu_book
wikipedia NEUTRAL — Samuel Harris Altman (born April 22, 1985) is an American entrepreneur who has been the chief executive officer (CEO) of the artificial intelligence company OpenAI since 2019. Altman attended Stanford…
https://en.wikipedia.org/wiki/Sam_Altman
menu_book
wikipedia NEUTRAL — On November 17, 2023, OpenAI's board of directors ousted co-founder and chief executive Sam Altman. In an official post on the company's website, it was stated that "the board no longer has confidence…
https://en.wikipedia.org/wiki/Removal_of_Sam_Altman_from_Ope…
menu_book
wikipedia NEUTRAL — OpenAI is an American artificial intelligence (AI) research organization headquartered in San Francisco, consisting of a for-profit public benefit corporation (PBC) partially controlled by a nonprofit…
https://en.wikipedia.org/wiki/OpenAI
+ 5 more evidence sources
check_circle
Claim 4: “On 14 April, OpenAI announced a partnership with the Danish pharmaceutical company Novo Nordisk to “help the company bring new and better treatment options to patients faster”.”
CORROBORATED
The Lucid Diligence Brief specifically mentions the April 14, 2026, OpenAI announcement regarding a partnership with Novo Nordisk.
menu_book
wikipedia NEUTRAL — ABB Group is a Swedish-Swiss technology company, that operates in the fields of electrification and automation. The company was formed in 1988 from the merger of two electrical engineering companies, …
https://en.wikipedia.org/wiki/ABB
menu_book
wikipedia NEUTRAL — The Novo Nordisk Foundation (NNF) is a Danish enterprise foundation based in Hellerup, Denmark. Established in 1924, it supports research and other activities primarily in health, sustainability, and …
https://en.wikipedia.org/wiki/Novo_Nordisk_Foundation
menu_book
wikipedia NEUTRAL — Sandvik AB is a Swedish multinational engineering company specializing in products and services for mining, rock excavation, rock drilling, rock processing (crushing and screening), metal cutting and …
https://en.wikipedia.org/wiki/Sandvik
+ 3 more evidence sources
check_circle
Claim 5: “The new tool, called GPT-Rosalind, is named after Rosalind Franklin, a British scientist best known for her role in the discovery of the structure of DNA.”
CORROBORATED
Web sources (AOL, LinkedIn) confirm the model is named after Rosalind Franklin, and Wikipedia verifies Rosalind Franklin's identity as a British scientist central to the discovery of DNA structure.
menu_book
wikipedia NEUTRAL — Rosalind Elsie Franklin (25 July 1920 – 16 April 1958) was an English chemist and X-ray crystallographer. Her work was central to the understanding of the molecular structures of DNA (deoxyribonucleic…
https://en.wikipedia.org/wiki/Rosalind_Franklin
menu_book
wikipedia NEUTRAL — The following scientific events occurred in 2023.
https://en.wikipedia.org/wiki/2023_in_science
travel_explore
web search NEUTRAL — OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.
https://openai.com/index/introducing-gpt-rosalind/
+ 2 more evidence sources
check_circle
Claim 6: “OpenAI said it is working with biotechnology and pharmaceutical companies, and research centres such as Amgen, Moderna, the Allen Institute, and Thermo Fisher Scientific to apply GPT‑Rosalind across workflows that accelerate research and discovery.”
CORROBORATED
Multiple sources (IntuitionLabs, CoinCentral, and OpenAI) list Amgen, Moderna, the Allen Institute, and Thermo Fisher Scientific as partners/collaborators.
travel_explore
web search NEUTRAL — OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.Thermo Fisher Scientific. Moderna…
https://openai.com/index/introducing-gpt-rosalind/
travel_explore
web search NEUTRAL — Analyze OpenAI's GPT-Rosalind, a biochemical reasoning model for life sciences. Learn how Amgen, Moderna, and Thermo Fisher apply this AI to drug discovery.
https://intuitionlabs.ai/articles/openai-gpt-rosalind-bioche…
travel_explore
web search NEUTRAL — Partners include Amgen, Moderna, Thermo Fisher Scientific, the Allen Institute, and Novo Nordisk. Thermo Fisher Scientific holds a GF Score of 86/100, though insiders sold $8.2 million in shares over …
https://coincentral.com/openai-launches-gpt-rosalind-ai-mode…
check_circle
Claim 7: “OpenAI has launched a new artificial intelligence model designed to support research across biology, drug discovery, and translational medicine.”
CORROBORATED
Multiple independent web sources (AI News Today, AOL, and others) confirm OpenAI launched GPT-Rosalind for biology, drug discovery, and translational medicine.
travel_explore
web search NEUTRAL — OpenAI has introduced GPT-Rosalind, a new AI model designed to support life sciences research. The model aims to accelerate scientific research and drug discovery by optimizing workflows in biology, c…
https://www.linkedin.com/posts/ai-tower-official_ai-ainews-a…
travel_explore
web search NEUTRAL — OpenAI has launched GPT Rosalind, a new AI model built for biology, drug discovery, and translational medicine. The model is available as a research preview in ChatGPT, Codex, and the API for qualifie…
https://justainews.com/companies/openai/openai-launches-gpt-…
travel_explore
web search NEUTRAL — OpenAI’s latest AI model is built to do far more than offer cooking advice or create a spreadsheet. GPT-Rosalind, the company’s first model specifically built for life science, is meant to help scient…
https://ainewstoday.co/openai-has-a-new-ai-model-built-for-b…
verified
Claim 8: “Stéphane Bancel, Chief Executive Officer at Moderna.”
VERIFIED BY REFERENCE
Wikipedia and multiple web sources explicitly confirm Stéphane Bancel is the CEO of Moderna.
menu_book
wikipedia NEUTRAL — The Moderna COVID‑19 vaccine, sold under the brand name Spikevax among others, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infe…
https://en.wikipedia.org/wiki/Moderna_COVID-19_vaccine
menu_book
wikipedia NEUTRAL — Stéphane Bancel (born 20 July 1972) is a French business executive. He is the chief executive officer (CEO) of the American pharmaceutical and biotechnology company Moderna, known for its COVID-19 vac…
https://en.wikipedia.org/wiki/Stéphane_Bancel
menu_book
wikipedia NEUTRAL — Moderna, Inc. ( mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a co…
https://en.wikipedia.org/wiki/Moderna
+ 3 more evidence sources
check_circle
Claim 9: “The company stated it is also more effective at using scientific tools and databases in multi-step workflows such as literature review, sequence-to-function interpretation, experimental planning, and data analysis.”
CORROBORATED
Euronews and Towards AI both explicitly mention the model's effectiveness in multi-step workflows like literature review and experimental planning.
travel_explore
web search NEUTRAL — OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.
https://openai.com/index/introducing-gpt-rosalind/
travel_explore
web search NEUTRAL — The company stated it is also more effective at using scientific tools and databases in multi-step workflows such as literature review, sequence-to-function interpretation, experimental planning, and …
https://www.euronews.com/health/2026/04/17/what-to-know-abou…
travel_explore
web search NEUTRAL — OpenAI says it delivers the best performance on tasks that require reasoning over molecules, proteins, genes, pathways, and disease-relevant biology, and is more effective at using scientific tools an…
https://pub.towardsai.net/openais-biggest-week-wasn-t-about-…
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.